New cancer drug trial challenges standard treatment

NCT ID NCT07228832

Recruiting now Disease control Sponsor: Summit Therapeutics Source: ClinicalTrials.gov ↗

Summary

This study compares two different drug combinations for people newly diagnosed with advanced colorectal cancer that has spread. About 600 participants will receive either a new drug called ivonescimab or the standard drug bevacizumab, both combined with chemotherapy. The goal is to see which combination better controls cancer growth and extends life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Study Site
RECRUITING

Goodyear, Arizona, 85338, United States
Clinical Study Site
RECRUITING

Beverly Hills, California, 90212, United States
Clinical Study Site
RECRUITING

Cerritos, California, 90703, United States
Clinical Study Site
RECRUITING

Corona, California, 92882, United States
Clinical Study Site
RECRUITING

Duarte, California, 91010, United States
Clinical Study Site
RECRUITING

Huntington Beach, California, 92648, United States
Clinical Study Site
RECRUITING

Irvine, California, 92612, United States
Clinical Study Site
RECRUITING

Irvine, California, 92618, United States
Clinical Study Site
RECRUITING

Los Angeles, California, 90067, United States
Clinical Study Site
RECRUITING

Murrieta, California, 92562, United States
Clinical Study Site
RECRUITING

Orange, California, 92868, United States
Clinical Study Site
RECRUITING

Pasadena, California, 91030, United States
Clinical Study Site
RECRUITING

Torrance, California, 90503, United States
Clinical Study Site
RECRUITING

Upland, California, 91786, United States
Clinical Study Site
RECRUITING

West Hollywood, California, 90048, United States
Clinical Study Site
RECRUITING

New Haven, Connecticut, 06520-8028, United States
Clinical Study Site
RECRUITING

Norwich, Connecticut, 06360, United States
Clinical Study Site
RECRUITING

Hialeah, Florida, 33013, United States
Clinical Study Site
RECRUITING

Port Saint Lucie, Florida, 34952, United States
Clinical Study Site
RECRUITING

Newnan, Georgia, 30265, United States
Clinical Study Site
RECRUITING

Elmhurst, Illinois, 60540, United States
Clinical Study Site
RECRUITING

O'Fallon, Illinois, 62269, United States
Clinical Study Site
RECRUITING

Fort Wayne, Indiana, 46804, United States
Clinical Study Site
RECRUITING

Edgewood, Kentucky, 41017, United States
Clinical Study Site
RECRUITING

Saint Louis Park, Minnesota, 55426, United States
Clinical Study Site
RECRUITING

Billings, Montana, 59102, United States
Clinical Study Site
RECRUITING

Lincoln, Nebraska, 68506, United States
Clinical Study Site
RECRUITING

Cincinnati, Ohio, 45220, United States
Clinical Study Site
RECRUITING

Hermitage, Tennessee, 37129, United States
Clinical Study Site
RECRUITING

Fort Worth, Texas, 76104, United States
Clinical Study Site
RECRUITING

Salt Lake City, Utah, 84106, United States
Clinical Study Site
RECRUITING

Spokane, Washington, 99208, United States
Clinical Study Site
RECRUITING

Tacoma, Washington, 98405, United States
Clinical Study Site
RECRUITING

Montreal, Quebec, H4A 3J1, Canada
Clinical Study Site
RECRUITING

Chiba, 260-8717, Japan
Clinical Study Site
RECRUITING

Fukuoka, 812-8582, Japan
Clinical Study Site
RECRUITING

Hokkaido, 060-8648, Japan
Clinical Study Site
RECRUITING

Osaka, 541-8567, Japan
Clinical Study Site
RECRUITING

Tokyo, 104-0045, Japan
Clinical Study Site
RECRUITING

Rio Piedras, 00935, Puerto Rico

Conditions

Explore the condition pages connected to this study.

METASTATIC COLORECTAL CANCER (CRC)